Filing Details
- Accession Number:
- 0000899243-18-018316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-27 16:24:20
- Reporting Period:
- 2018-06-25
- Accepted Time:
- 2018-06-27 16:24:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1690585 | Magenta Therapeutics Inc. | MGTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741286 | Jason Gardner | C/O Magenta Therapeutics, Inc. 50 Hampshire Street Cambridge MA 02139 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-06-25 | 25,719 | $0.00 | 292,990 | No | 4 | C | Indirect | By J.P. Gardner Irrevocable Trust |
Common Stock | Acquisiton | 2018-06-25 | 21,677 | $0.00 | 359,092 | No | 4 | C | Indirect | By P.S. Gardner Irrevocable Trust |
Common Stock | Acquisiton | 2018-06-25 | 400 | $15.00 | 363,212 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By J.P. Gardner Irrevocable Trust |
No | 4 | C | Indirect | By P.S. Gardner Irrevocable Trust |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2018-06-25 | 30,000 | $0.00 | 11,611 | $0.00 |
Common Stock | Series A Preferred Stock | Disposition | 2018-06-25 | 36,700 | $0.00 | 14,203 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2018-06-25 | 15,000 | $0.00 | 5,804 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2018-06-25 | 19,314 | $0.00 | 7,474 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2018-06-25 | 21,459 | $0.00 | 8,304 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Preferred Stock had no expiration date.
- Reflects shares that were purchased through a directed share program in connection with the Issuer's initial public offering.